| | | Single nucleotide variant (missense variant) | Paragangliomas 4 +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary nonpolyposis colorectal neoplasms +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense +2 more) | PMS1-related breast cancer | |
| | | Single nucleotide variant (missense variant +1 more) | PMS1-related breast cancer | |
| | | Single nucleotide variant (missense variant +2 more) | not specified +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer +5 more | |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (nonsense +2 more) | BARD1-related condition +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (nonsense +2 more) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant +2 more) | BARD1-related condition +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | not specified +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast cancer, ABRAXAS1-related +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +7 more | GConflicting classifications of pathogenicity; association; risk factor |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | HMMR, HMMR-AS1 (V556A +3 more) | Single nucleotide variant (missense variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Microcephaly, normal intelligence and immunodeficiency +2 more | |
| | | Microsatellite (inframe_deletion) | PTEN hamartoma tumor syndrome +2 more | |
| | CYP17A1, CYP17A1-AS1 (R239*) | Single nucleotide variant (nonsense) | Deficiency of steroid 17-alpha-monooxygenase +1 more | |
| | | Single nucleotide variant (missense variant) | Triple-negative breast cancer | |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast | |
| | | Single nucleotide variant (nonsense) | Ataxia-telangiectasia syndrome +4 more | |
| | | Deletion (frameshift variant) | Ataxia-telangiectasia syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense) | Ataxia-telangiectasia syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense) | Ataxia-telangiectasia syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense) | not provided +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast +4 more | |
| | | Indel (frameshift variant) | Familial cancer of breast | |
| | | Single nucleotide variant (nonsense) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (nonsense +1 more) | Breast cancer, susceptibility to +4 more | |
| | | Single nucleotide variant (nonsense +1 more) | ATM-related condition +6 more | |
| | | Deletion (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast | |
| | | Single nucleotide variant (missense variant +1 more) | Ataxia-telangiectasia syndrome | |
| | | Deletion (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Microsatellite (splice donor variant +1 more) | Ataxia-telangiectasia syndrome +5 more | |
| | | Single nucleotide variant (nonsense +1 more) | Ataxia-telangiectasia syndrome +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice acceptor variant +1 more) | Ataxia-telangiectasia syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Breast cancer, susceptibility to +1 more | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (missense variant) | Hereditary breast ovarian cancer syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Duplication (frameshift variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Duplication (frameshift variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not provided | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group P +1 more | |
| | | Single nucleotide variant (nonsense) | PALB2-Related Disorders +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | PALB2-related condition +6 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | Breast and/or ovarian cancer +6 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast | |
| | | Deletion (frameshift variant) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | Familial cancer of breast +5 more | |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group N +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice acceptor variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Deletion (frameshift variant) | Pancreatic cancer, susceptibility to, 3 +4 more | |
| | | Deletion (frameshift variant) | Familial cancer of breast | |
| | | Single nucleotide variant (missense variant) | Breast cancer, susceptibility to +1 more | |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Deletion (frameshift variant) | PALB2-related condition +11 more | |
| | | Single nucleotide variant (nonsense) | PALB2-related disorder +5 more | |
| | | Deletion (frameshift variant) | Breast cancer, susceptibility to +6 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice donor variant +1 more) | Pancreatic cancer, susceptibility to, 3 +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Microsatellite (5 prime UTR variant) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant +2 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant +2 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant +2 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant +2 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (missense variant +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (nonsense +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (nonsense +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (nonsense +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Microsatellite (inframe_insertion +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Microsatellite (inframe_insertion +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | CDH1-related diffuse gastric and lobular breast cancer syndrome | |